Regulators were right to ease the burdens for an IPO, but they failed to close loopholes for exploiting share prices and transfers. Though the new Measures enhance supervision, a paradox remains: more control is needed before China's stock market can be liberalised
China and US regulators are working on a deal, but if China wants regulatory equivalency it must first prove its intent to prosecute fraud, says accounting professor Paul Gillis